Monovalent synthetic carbohydrate-based conjugate Shigella vaccine (University of Maryland, Baltimore)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMonovalent synthetic carbohydrate-based conjugate Shigella vaccine (University of Maryland, Baltimore)

Drug Alias Name基于单价合成碳水化合物的缀合物志贺氏菌疫苗-马里兰大学巴尔的摩分校SF2a-TT15

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Univalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDysentery, Bacillary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Maryland, Baltimore

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore

Inactive CompaniesN/A

Active IndicationsDysentery, Bacillary

Inactive IndicationsN/A

Other Information

ATC CodeN/A